Healthcare ❯ Pharmaceuticals ❯ Clinical Trials

Phase II Trials

Amgen Reports Year-Long Weight-Loss Maintenance With Monthly or Quarterly MariTide Dosing

The company says less-frequent injections could improve patient persistence versus weekly drugs.